Staff Data Search - جامعة الزقازيق

Personal Website
Curriculum Vitae

Hanan Mohamed Mahmoud Mostafa Elnahas

Faculty pharmacy - Department Pharmaceutics Department
NULL

Scientific degrees

BSc In NULL, [1991]
MSc In NULL, [1996]
PhD In NULL, [2001]

الحالة الوظيفية الحالية :

قائم بالعمل

Academic Jobs

معيد : 6/2/1992
Doctor Assisant : 8/10/1996
Doctor : 27/11/2001
Professor Assisant : 24/7/2007
Professor : 26/3/2013

Publications

1 - AStudy of certain formulations of Controlled drug delivery systems

2 - Liposomal gel as Ocular Delivery System for Diclofenac sodium: In- Vitro and In-Vivo Studies (2012).

3 - FORMULATION AND EVALUATION OF CARBAMAZEPINE 200 MG CHEWABLE TABLETS USING CYCLODEXTRINS (2012).

4 - Propolis organogel as a novel topical delivery system for treating wounds (2013).

5 - Formulation and Evaluation of Carbamazepine 200 mg Controlled Release Tablets Using Different HPMC Grades Formulation and Evaluation of Carbamazepine 200 mg Controlled Release Tablets Using Different HPMC Grades Formulat (2013).

6 - FORMULATION AND EVALUATION OF CARBAMAZEPINE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL 6000 AND THEIR INCORPORATION INTO TABLETS (2013).

7 - Development and Characterization of Controlled Release Ketoprofen Microspheres (2012).

8 - Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model (2016).

9 - BUCCOADHESIVE TABLETS FOR DELIVERY OF VERAPAMIL HCL: DESIGN, IN VITRO ANALYSIS AND IN-VIVO EVALUATION Fakhr El Din S. Ghazy, Mohamed A. Gad, Hanan M. El-Nahas, Noura G. Eissa . Bull. Pharm. Sci., Assiut University, Vol. 35, Part 1, 17-25(01 (2014).

10 - Atorvastatin Calcium Solid Dispersion in Floating Tablets for Hypolipedmic Effect. (2016).

11 - OPTIMISATION AND CHARACETRISATION OF EUDRAGIT S 100 MICROSPONGES OF FLUCONAZOLE (2016).

12 - Optimization and Characterization of Eudragit S 100 Microsponges of Fluconazole (2016).

13 - Optimization of injectable PLGA in-situ forming implants of anti-psychotic risperidone via Box-Behnken Design (2020).

14 - Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles (2020).

15 - Comparative Study of PLGA in-situ Implant and Nanoparticle Formulations of Entecavir; in-vitro and in-vivo evaluation (2020).

16 - Brucine PEGylated nanoemulsion: In vitro and in vivo evaluation (2021).

17 - Fast disintegrating tablet of Doxazosin Mesylate nanosuspension: Preparation and characterization (2020).

18 - An overview of PLGA in-situ forming implants based on solvent exchange technique: effect of formulation components and characterization (2021).

19 - Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats (2021).

20 - Basic Concepts of Nanoemulsion and its Potential application in Pharmaceutical, Cosmeceutical and Nutraceutical fields (2021).

21 - A Review Article on the Basic Concepts of Drug Delivery Systems as Targeting Agents (2021).

22 - Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats (2022).

23 - Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion (2022).

24 - Development, Characterization and Optimization of the Anti-Inflammatory Influence of Meloxicam Loaded into a Eucalyptus Oil-Based Nanoemulgel (2022).

25 - Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: in-vitro characterization and in-vivo assessment (2022).

26 - Brain-targeted delivery of Valsartan using solid lipid nanoparticles labeled with Rhodamine B; a promising technique for mitigating the negative effects of stroke (2023).

27 - Significant of injectable brucine PEGylated niosomes in treatment of MDA cancer cells (2022).

28 - Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients (2023).

29 - Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control (2023).

30 - Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity (2023).

31 - Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route (2023).

32 - The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment (2023).

33 - Design of mirtazapine solid dispersion with different carriers’ systems: optimization, in vitro evaluation, and bioavailability assessment (2023).

34 - Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs (2023).

35 - Association of SLC22A1, SLC47A1, and KCNJ11 polymorphisms with efficacy and safety of metformin and sulfonylurea combination therapy in Egyptian patients with type 2 diabetes (2023).

36 - Maximizing the Use of Ivermectin Transethosomal Cream in the Treatment of Scabies (2024).

37 - The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats (2024).

38 - Evaluation of Mucoadhesive Nano-Bilosomal In Situ Gels Containing Anti-Psychotic Clozapine for Treatment of Schizophrenia: In Vitro and In Vivo Studies (2024).

39 - Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats (2024).

40 - Experimental Investigation into the Design, Optimization, Toxicity, and Anti-Viral Efficacy of Proliposomes Loaded with Ivermectin Against Infectious Bronchitis Virus Using an Embryonated Chicken Egg Model (2025).

41 - Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems (2024).

42 - 24 Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation. (2024).

43 - Exploring Ventilator-Associated Pneumonia: Microbial Clues and Biomarker Insights from a Retrospective Study (2024).

44 - Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes (2024).

Research Area